Chemoprevention in Lynch syndrome - Wikidata - awgldk - TriplyDB

Chemoprevention in Lynch syndrome

Chemoprevention in Lynch syndrome

http://www.wikidata.org/entity/Q56435752

about

Realizing the promise of cancer predisposition genes.Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention.Ulcerative colitis: from inflammation to cancer. Do estrogen receptors have a role?Mainstreaming genetic testing of cancer predisposition genes.Advances in the study of Lynch syndrome in China Hereditary and common familial colorectal cancer: evidence for colorectal screening.Epithelial MUC1 promotes cell migration, reduces apoptosis and affects levels of mucosal modulators during acetylsalicylic acid (aspirin)-induced gastropathy.Commentary on 'Colonoscopy screening compliance and outcomes in patients with Lynch syndrome'.Effect of aspirin on tumour cell colony formation and evolution.Effect of cell cycle duration on somatic evolutionary dynamics.Cost-effectiveness of routine screening for Lynch syndrome in colorectal cancer patients up to 70 years of age.Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD)Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas Systematic review update of observational studies further supports aspirin role in cancer treatment: Time to share evidence and decision-making with patients?

P2860

Q30743260-948C59E4-9E7F-4A59-8ED8-5426951841CE Q33661094-3E3B1B50-2DE5-4421-90E4-72F00D2B083A Q34137246-A87538BC-0D29-4505-B17B-C60AB866EC86 Q35034822-0FA579F2-4440-48E3-9FC3-DE0B05D2ADD9 Q35716138-2F020167-CBF0-48A8-8C19-333F9C44634D Q38287107-D73ACC78-B099-4CDC-836B-F5BAB0DC6B38 Q38941294-1487F674-3BC8-42EE-8F7B-68128D13C5A2 Q46051976-80B7670A-92FB-4E7E-9002-B87F20637C49 Q46722923-79E9FE58-C09A-4742-8696-45D9114546DA Q47605330-6A7EE007-3988-497D-B524-5DF97B51328C Q50873130-33327447-3D2A-44AC-B590-A5C9082B87C3 Q57316200-DCE2B772-7A3C-45D6-8DA4-B0D07728FB6B Q57646224-829254BC-A219-47AC-9F7A-1A128F0A734C Q58699234-2972DFF3-6389-43D5-82C3-77FBBD327EDB

P2860

Chemoprevention in Lynch syndrome

http://www.wikidata.org/entity/Q56435752

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в липні 2013

@uk

ലേഖനം

@ml

name

Chemoprevention in Lynch syndrome

@en

Chemoprevention in Lynch syndrome

@nl

type

label

Chemoprevention in Lynch syndrome

@en

Chemoprevention in Lynch syndrome

@nl

prefLabel

Chemoprevention in Lynch syndrome

@en

Chemoprevention in Lynch syndrome

@nl

P1433

Q56435752-AD9AE47E-2C50-4A04-9A92-68893F089616

P1476

Q56435752-3AE2D3F6-7A8B-47BD-87E1-2453481575B9

P2093

Q56435752-6952CF82-87C7-4BD3-877D-913DC5722850

Q56435752-E81F4417-2D6F-4B0E-A308-A370A6735C83

P2860

Q56435752-254F0D15-DC71-49B9-9213-D5ECBC1E9B2D

Q56435752-2B9A7AB8-F7FA-495A-86A4-AE4B5116DD13

Q56435752-2F640D28-9044-4DB1-B73D-F7A86F335339

Q56435752-31EE1E30-C2C7-46BD-97EB-421C88C36B32

Q56435752-3E1502F0-F35C-496B-B35A-D6657046EC35

Q56435752-487FAB45-29E4-4076-973A-39F39A3BD2F8

Q56435752-50C30393-EDCF-43C9-B771-246BA2EA7D36

Q56435752-5250D336-B3E6-4194-978C-3E348EEC0EBC

Q56435752-52D6340A-8365-4592-B3AB-6AF448B69ECF

Q56435752-6EA0E466-845E-46E2-B979-2625CCF45986

P2888

Q56435752-8D8C8253-1E88-4C29-BB4B-6A1E6E31DB3A

P304

Q56435752-183C1A62-BDF7-44A9-AE11-D3B70498DCAE

P31

Q56435752-8E1D7DF4-4F53-46AE-8D70-20F695D7BF97

P356

Q56435752-E8961B82-622A-4A40-9876-1B85FCF88018

P433

Q56435752-B2C505EE-3621-4E59-9632-3694ADB6C32F

P478

Q56435752-2BEE45F8-2FB2-4550-93B1-93A9D8104398

P50

Q56435752-37883E96-FBF4-4EEA-B475-52D2EE7DCFBE

Q56435752-51DDE5F3-A9AF-4588-A06C-C5E7F4454EC6

Q56435752-B6E96A5E-120D-4B40-9987-11FC21828A0B

P577

Q56435752-ABCD675D-690F-4B00-A04E-A6B5A2237756

P698

Q56435752-100E8419-52E8-42EE-8247-3442987AC4DE

P356

S10689-013-9650-Y

P1433

Familial Cancer

P1476

Chemoprevention in Lynch syndrome

@en

P2093

D. Tim Bishop

http://www.w3.org/2001/XMLSchema#string

John C. Mathers

http://www.w3.org/2001/XMLSchema#string

P2860

Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies

Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.

Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanism

Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies

The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

Aspirin use and reduced risk of fatal colon cancer.

Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability.

Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.

A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis.

P2888

s10689-013-9650-y

P304

707-718

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10689-013-9650-Y

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

John C. Mathers

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23880960

http://www.w3.org/2001/XMLSchema#string